PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30194031-0	2020	ODM-204, a Novel Dual Inhibitor of CYP17A1 and Androgen Receptor: Early Results from Phase I Dose Escalation in Men with Castration-resistant Prostate Cancer.	ODM-204	0-7	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	35-42	
30194031-5	2020	INTERVENTION: ODM-204, a novel, orally administered, investigational, nonsteroidal dual inhibitor of CYP17A1 and androgen receptor.	ODM-204	14-21	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	101-108